Home › High Blood Pressure › NCT07413159
The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
Check, Monitor, Control Hypertension in Older African American Adults (#Check, Monitor, Control)
Who can join
Ages 55 and older · All sexes
Full eligibility criteria
Inclusion Criteria: Individuals are eligible to the study if they are: * 55 years or older * Have at least 2 high blood pressure readings ≥ 130/80 mmHg within one month * Past Medical History of hypertension \> 1 year * Taking at least 1 antihypertensive medication * Independent Activities of Daily Livings (ADL) and instrumental Activities of Daily Livings (iADL) * Have a SmartPhone * Live within the Greater Houston Metropolitan Areas * Able to speak English Exclusion criteria: * Unable to verbalize comprehension of study or impaired cognitive function (e.g. dementia) * Not able to monitor blood pressure at home * Plans to relocate outside Houston within the next year
About the study
The proposed study, "Check, Monitor, Control Hypertension in Older African American Adults," is a randomized clinical trial designed to improve blood pressure control among African American adults aged 55 years and older in the Greater Houston area. Hypertension disproportionately affects African Americans, contributing to higher rates of cardiovascular disease and stroke. This project aims to improve clinical and behavioral outcomes through a 24-month intervention combining pharmacist-led counseling and Community Health Worker (CHW) support.
What is being tested
- Pharmacists Only (Control Group) (other)
- Combined Intervention (Pharmacists + CHW Interventions) (other)
Sponsor: Texas Southern University · Participants: 480 · Started: Jun 1, 2026
Contact the study team
- Ivy 0 Poon, Pharm.D., M.S., BCPS · Phone: 713-313-4400
Official record on ClinicalTrials.gov — NCT07413159
Locations in the U.S.
| Texas | 3100 Cleburne Street, Nabrit Science Building,, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.